FOX - Diagnos: A Leader in Artificial Intelligence & Healthcare Technical Services Since 2001

Diagnos is a publicly-traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence …

December 15, 2021
Request Investor InfoRequest Investor Info
Diagnos Inc.

An AI company

Diagnos is a publicly-traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and development of applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

For more information on Diagnos Inc. (TSX.V: ADK) please click the request investor info button.

stock market
stock picks
stocks
stocks to buy

You might also like

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs
Life Sciences
August 28, 2026

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
August 27, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
August 27, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info